AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 121 filers reported holding AKEBIA THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is 0.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $77 | +4.1% | 75,079 | +26.2% | 0.01% | -16.7% |
| Q4 2023 | $74 | +60.9% | 59,479 | +17.5% | 0.01% | +50.0% |
| Q2 2023 | $46 | -16.4% | 50,633 | -48.3% | 0.00% | -33.3% |
| Q1 2023 | $55 | -99.9% | 97,854 | -25.3% | 0.01% | -14.3% |
| Q1 2022 | $94,000 | -46.3% | 130,949 | +183.0% | 0.01% | -58.8% |
| Q2 2021 | $175,000 | -68.4% | 46,270 | -71.7% | 0.02% | -56.4% |
| Q1 2021 | $554,000 | +167.6% | 163,532 | +98.7% | 0.04% | +8.3% |
| Q3 2020 | $207,000 | +68.3% | 82,303 | +322.3% | 0.04% | +200.0% |
| Q4 2019 | $123,000 | +66.2% | 19,491 | +2.9% | 0.01% | +100.0% |
| Q3 2019 | $74,000 | -52.6% | 18,948 | -32.8% | 0.01% | -25.0% |
| Q4 2018 | $156,000 | +54.5% | 28,181 | +179.1% | 0.01% | +100.0% |
| Q2 2018 | $101,000 | -54.7% | 10,097 | -56.8% | 0.00% | -66.7% |
| Q1 2018 | $223,000 | +21.2% | 23,352 | +88.5% | 0.01% | +20.0% |
| Q4 2017 | $184,000 | -9.8% | 12,387 | +19.4% | 0.01% | 0.0% |
| Q3 2017 | $204,000 | – | 10,372 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 4,652,561 | $13,027,000 | 5.13% |
| Orchard Capital Management, LLC | 857,138 | $2,400,000 | 1.02% |
| Nantahala Capital Management | 7,040,487 | $19,713,000 | 0.61% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 209,040 | $585,000 | 0.18% |
| Woodline Partners LP | 2,382,522 | $6,671,000 | 0.18% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,546,169 | $4,329,000 | 0.15% |
| Virtus ETF Advisers LLC | 92,771 | $260,000 | 0.11% |
| Jump Financial, LLC | 155,583 | $435,000 | 0.07% |
| GSA CAPITAL PARTNERS LLP | 128,626 | $360,000 | 0.06% |
| Anson Funds Management LP | 95,342 | $267,000 | 0.05% |